Background
and Goals: Diabetes is a chronic illness that necessitates long-term treatment.
Anti-diabetic drug non-adherence results in inadequate glycemic control, which
can lead to treatment failures, complications, and increased mortality. The
study's goal was to examine medication adherence among patients with type 2
diabetes mellitus. In patients with type 2 diabetes mellitus, the goal was to
assess adherence to therapy and investigate factors linked to nonadherence and
adherence. Materials and methods: A six-month cross-sectional observational
study was undertaken at three hospitals. A total of 200 type 2 diabetic
patients were enrolled, all of whom had been on anti-diabetic medication for at
least 6 months. The patient's blood glucose was measured, and the details of
his or her pharmacological therapy were recorded. The Morisky Medication
Adherence Scale was used to assess medication adherence, and adherence scores
were calculated. Only 15% of people had a high level of medication adherence,
while 24% had a moderate level and 61% had a low one. Only 30% of participants
had adequately managed glycemic levels, while 70% had uncontrolled glycemic
levels. Type II patients with uncontrolled glycemic levels had lower medication
adherence scores (indicating worse adherence) than those with optimally
controlled glycemic levels, although this difference was not statistically
significant. Overall, medication adherence was low in type II diabetes
patients. Interpretation and Conclusion: The findings show that better patient
counselling and health education are required to enhance drug adherence.
Adherent patients are more likely to attain glycemic control than non-adherent
patients, despite the fact that the majority of patients were on medication. To
enhance patient outcomes, more efforts are needed to support diabetic
self-management behaviours. There is a need to check patient adherence to
medication on a frequent basis and take actions to increase adherence to
anti-diabetic medications. As a result, patient counselling and health
education regarding drug adherence are essential.
Author (s) Details
Dr. T. Prathyusha Rani
Department of Pharmacy Practice, Telanagana, India.
B. Prashanthi
Department of Pharmacy Practice, Vaagdevi Institute of Pharmaceutical
Sciences, Telanagana, India.
Ayesha Amreen Fathima
Sri Indu Institute of Pharmaceutical Sciences, Telanagana, India.
Dr. Ayesha Firdose
Sri Indu Institute of Pharmaceutical Sciences, Telanagana, India.
Sara Naser
Sri Indu Institute of Pharmaceutical Sciences, Telanagana, India.
Mohammed Najma Unnisa
Sri Indu Institute of Pharmaceutical Sciences, Telanagana, India.
Dr. Kauser Begum
Sri Indu Institute of Pharmaceutical Sciences, Telanagana, India.
View Book :- https://stm.bookpi.org/TIPR-V9/article/view/2515
Thursday, 12 August 2021
A Cross-sectional Study on Medication Adherence in Patients with Type 2 Diabetes Mellitus| Chapter 2 | Technological Innovation in Pharmaceutical Research Vol. 9
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment